The continuing dissection of the molecular phenotype of mGluR2−/− and mGluR3−/− mice will contribute to the understanding of the relative contribution of each receptor in the aetiopathogenesis and pharmacotherapy of schizophrenia and other psychiatric disorders in which they are increasingly implicated. This evidence concerns the gene GRM3 and schizophrenia.